SHBG and metabolic dysfunction-associated steatotic liver disease: In order to confirm the reliability of SHBG <33.4 nmol/L as a marker of metabolic impairment and increased NAFLD risk, a second larger independent cohort of women with sexual dysfunction was analyzed.